Organ biodistribution, clearance, and genotoxicity of orally administered zinc oxide nanoparticles in mice

Abstract Understanding tissue biodistribution and clearance of zinc oxide nanoparticles (ZnO-NPs) is necessary for its risk assessment. Both fed and intraperitoneally injected ZnO-NPs (2.5 g/kg) were absorbed into circulation (within 30 min post-dosing), then biodistributed to the liver, spleen, and...

Full description

Saved in:
Bibliographic Details
Published inNanotoxicology Vol. 6; no. 7; pp. 746 - 756
Main Authors Li, Ching-Hao, Shen, Chuan-Chou, Cheng, Yu-Wen, Huang, Shih-Hsuan, Wu, Chung-Che, Kao, Chen-Chieh, Liao, Jiunn-Wang, Kang, Jaw-Jou
Format Journal Article
LanguageEnglish
Published England Informa UK, Ltd 01.11.2012
Taylor & Francis
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Abstract Understanding tissue biodistribution and clearance of zinc oxide nanoparticles (ZnO-NPs) is necessary for its risk assessment. Both fed and intraperitoneally injected ZnO-NPs (2.5 g/kg) were absorbed into circulation (within 30 min post-dosing), then biodistributed to the liver, spleen, and kidney. Intraperitoneally injected ZnO-NPs remained in serum for 72 h and could more effectively spread to the heart, lung, and testes, whereas the clearance for fed ZnO-NPs in serum began 6 h after oral administration. Compared with zinc oxide microparticles (ZnO-MPs), ZnO-NPs exhibited much higher absorptivity and tissue biodistribution in fed treatment. A greater fraction of fed ZnO-NPs localised in the liver resulted in transient histopathological lesions. However, superoxide generation and cytotoxicity were showed in vitro treatment with ZnO-NPs (above 20 μg/mL). Considering both in vitro and in vivo data, the ZnO-NPs induced acute liver toxicity which was in compliance with its absorption, biodistribution, and clearance.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
ISSN:1743-5390
1743-5404
1743-5404
DOI:10.3109/17435390.2011.620717